RAPTRAPT Therapeutics, Inc.

$959M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$37M

Net Income

-$36M

EPS (Diluted)

$-13.59

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$36M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$70M

Total Liabilities

$6M

Stockholders' Equity

$64M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	+10.6%
Operating Income	-$37M	-$29M	-26.0%
Net Income	-$36M	-$29M	-24.2%

RAPT FY 2018 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena